Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-11

Clinical Trial Update: Quetiapine XR in Schizophrenic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial of quetiapine XR for schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine XR (quetiapine)

Snippet

Sponsor: Hannover Medical School | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED